BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Paradigms Foundation - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://paradigms.foundation
X-WR-CALDESC:Events for Paradigms Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260904T140000
DTEND;TZID=Europe/Paris:20260904T180000
DTSTAMP:20260901T123003Z
CREATED:20260603T145017Z
LAST-MODIFIED:20260901T123003Z
UID:14377-1788530400-1788544800@paradigms.foundation
SUMMARY:Scientific meeting: Multiple Sclerosis - Multiple Predictors in Disease Prognostication
DESCRIPTION:The scientific meeting chaired by ParadigMS expert Maura Pugliatti will be exploring current and emerging predictors of disease progression in Multiple Sclerosis.\n\n\n\nRegistration\n\n\n\nParticipation is free of charge\, but registration is required as places are limited. Please complete the registration form to confirm your attendance. \n\n\n\n\nRegister to attend the in-person scientific meeting\n\n\n\n\nMeeting details\n\n\n\nDate: Friday\, 4 September 2026Time: 13:00-18:10Location: Palazzo Roverella\, Ferrara\, ItalyRegistration: Free of chargeCME accreditation: No CME credits available \n\n\n\nUnderstanding disease progression remains one of the greatest challenges in Multiple Sclerosis (MS) care. This scientific meeting will bring together leading international experts to examine the diverse factors that contribute to disease prognostication\, from clinical and biological markers to emerging technologies and predictive models. \n\n\n\nParticipants will explore current evidence on pathophysiology\, biomarkers\, genetic studies\, registries\, comorbidities\, imaging\, and decision-support systems\, while discussing how these insights may support more personalized management strategies for people living with MS. \n\n\n\nDepliant_MS&NO_September4_DEFDownload\n\n\n\nDownload the programme \n\n\n\nScientific committee\n\n\n\n\nMaura Pugliatti\n\n\n\nCaterina Ferri\n\n\n\nNicola Merli\n\n\n\nMassimiliano Castellazzi\n\n\n\n\nProgramme overview\n\n\n\nSession I\n\n\n\nPrognostication in Multiple Sclerosis: Pathogenesis\, Pathophysiology and Clinical Presentation \n\n\n\n14:00Multiple sclerosis progression: pathophysiology and measurementsCelia Oreja-Guevara (Spain) \n\n\n\n14:20Clinical predictors of disease progressionBart Van Wijmeersch (Belgium) \n\n\n\n14:40Biomarkers in predicting multiple sclerosis worseningLaura Airas (Finland) \n\n\n\n15:00Prognostication from genetic studiesSandra D’Alfonso (Italy) \n\n\n\n15:20Investigating disease prognosis through data collection: the Italian MS RegistryPietro Iaffaldano (Italy) \n\n\n\n15:40Microchimerism in multiple sclerosisMichele Rubini (Italy) \n\n\n\n16:00Discussion \n\n\n\nSession II\n\n\n\nPrognostication in Multiple Sclerosis: Evidence About Less Conventional Predictors \n\n\n\n16:20Prognostication from cerebrospinal fluid analysisMassimiliano Castellazzi (Italy) \n\n\n\n16:40Comorbidities in multiple sclerosis progressionCaterina Ferri (Italy) \n\n\n\n17:00The role of ultrasound in prognosis through the study of the optic nerveNicola Merli (Italy) \n\n\n\nSession III\n\n\n\nPrognostication in Multiple Sclerosis: Moving Towards Algorithms and Decisional Support Systems \n\n\n\n17:20Decisional support systems\, modelling and algorithmsMassimiliano Copetti (Italy) \n\n\n\n17:40Prognostication in multiple sclerosis: the PROMISING StudyMaura Pugliatti (Italy) \n\n\n\n18:00Discussion \n\n\n\n18:10Closing remarksMaura Pugliatti (Italy) \n\n\n\nWhy attend?\n\n\n\nThis meeting offers a comprehensive overview of established and emerging predictors of disease progression in Multiple Sclerosis\, bringing together expertise from clinical practice\, epidemiology\, genetics\, biomarker research and data science. Attendees will gain practical insights into how prognostic tools may support more informed treatment decisions and personalised patient care. \n\n\n\nUnder the auspices of\n\n\n\n\nParadigMS\n\n\n\nUniversity of Ferrara\n\n\n\nFerrara University Hospital\n\n\n\nFerrara Health District\n\n\n\nItalian Society of Neurology (SIN)\n\n\n\nItalian Association of Neuroepidemiology (AINEP)\n\n\n\n\nSponsorships
URL:https://paradigms.foundation/event/scientific-meeting-multiple-sclerosis-multiple-predictors-in-disease-prognostication/
ATTACH;FMTTYPE=image/jpeg:https://paradigms.foundation/wp-content/uploads/2026/06/Palazzo.jpg
END:VEVENT
END:VCALENDAR